Pancreatic Cancer Research

ResearcherZhejiang Chinese Medical UniversityActive in the last 2 years

Hao Xu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-6459-1063; OpenAlex author ID A5100409269. Sources: OpenAlex.

Their work

Papers
6 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
14
Papers, trials and grants by year

2021: 2 papers · 2022: none · 2023: 1 paper · 2024: 3 papers

Papers 6

  1. Establishment and characterization of the PDAC-X3 cell line: a novel Chinese-origin pancreatic ductal adenocarcinoma cell line. Last author DOI 10.1007/s13577-024-01100-y↗
  2. A novel multidrug-resistant cell line from a Chinese patient with pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41598-024-56464-w↗
  3. Establishment and characterization of a novel multidrug-resistant pancreatic ductal adenocarcinoma cell line, PDAC-X1. Co-author DOI 10.1186/s12885-024-12588-w↗
  4. A risk signature based on endoplasmic reticulum stress-associated genes predicts prognosis and immunity in pancreatic cancer. Co-author DOI 10.3389/fmolb.2023.1298077↗
  5. miR-365 secreted from M2 Macrophage-derived extracellular vesicles promotes pancreatic ductal adenocarcinoma progression through the BTG2/FAK/AKT axis. First author DOI 10.1111/jcmm.16405↗
  6. LncRNA SNHG16 contributes to tumor progression via the miR-302b-3p/SLC2A4 axis in pancreatic adenocarcinoma. Co-author DOI 10.1186/s12935-020-01715-9↗

Closest collaborators

The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Wence Zhou · 4 shared papers, 2021–2024 · strength 0.71
  2. Changpeng Chai · 3 shared papers, 2024 · strength 0.55
  3. Huan Tang · 3 shared papers, 2024 · strength 0.55
  4. Cheng Yu · 3 shared papers, 2024 · strength 0.55
  5. Bo Zhang · 2 shared papers, 2021–2024 · strength 0.33
  6. Wence Zhou · 2 shared papers, 2021–2023 · strength 0.32
  7. Zhengfeng Wang · 2 shared papers, 2021–2024 · strength 0.32
  8. Xin Li · 2 shared papers, 2021 · strength 0.30
  9. Haofei Chen · 1 shared paper, 2023 · strength 0.18
  10. Daoming Liang · 1 shared paper, 2023 · strength 0.18
  11. Weixiong Zhu · 1 shared paper, 2023 · strength 0.18
  12. Xin Miao · 1 shared paper, 2021 · strength 0.16
  13. Chunlu Dong · 1 shared paper, 2021 · strength 0.14
  14. Hui Zhang · 1 shared paper, 2021 · strength 0.14

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.